Generation Bio Co. (GBIO)

US — Healthcare Sector
Peers: GLUE  NKTX  LYEL  SANA  KRON  ERAS  CCCC  EWTX  IPSC  PASG  FIXX  STOK  NUVB  STTK 

Automate Your Wheel Strategy on GBIO

With Tiblio's Option Bot, you can configure your own wheel strategy including GBIO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol GBIO
  • Rev/Share 0.3665
  • Book/Share 1.0945
  • PB 0.3289
  • Debt/Equity 1.1943
  • CurrentRatio 8.4257
  • ROIC -0.4255

 

  • MktCap 24132672.0
  • FreeCF/Share -1.2829
  • PFCF -0.2808
  • PE -0.3353
  • Debt/Assets 0.435
  • DivYield 0
  • ROE -0.7584

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
GBIO
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $1.12 per share a year ago.

Read More
image for news Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
GBIO
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. ET in Boston.

Read More
image for news Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

About Generation Bio Co. (GBIO)

  • IPO Date 2020-06-12
  • Website https://generationbio.com
  • Industry Biotechnology
  • CEO Dr. Cameron Geoffrey McDonough M.D.
  • Employees 115

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.